Special Discounted Hotel Rate Available Until Friday, April 18, 2014. To book your room, call 1-(800)-843-6664 and reference TIDES 2014.
Join 750 global oligonucleotide and peptide professionals at TIDES 2014, where you will access the latest science, technologies and regulations needed to advance your product from discovery to clinic to market.
Our 2014 program includes tons of exciting new updates, speakers and topics to keep you on the pulse of this evolving industry. Whether your focus is on oligonucleotides or peptides, discovery or manufacturing, TIDES 2014 is the one-stop conference to advance your research, development and process chemistry efforts forward.
Accelerate Your Therapeutic from Discovery to Clinic to Market
Accelerate Your Pipeline and Improve Your Manufacturing Operations
by accessing case studies, regulatory updates and lessons learned from 100 industry and academic presentations
Benchmark Your Current Development Efforts
by hearing preclinical and clinical successes and failures from peptides and oligonucleotides currently in development
Access Novel Technologies and Cutting-Edge Science
in the exhibit and poster hall, featuring over 75 exhibitors and 30 peer-submitted posters
Forge Scientific and Business Partnerships
by meeting 750 global oligonucleotide and peptide professionals during networking luncheons, cocktail receptions and refreshment breaks
"TIDES is the premier venue to network with the experts in peptide and oligonucleotide development and to be on the pulse of current status and future trends in Biotech and Pharma."- Alex Fӓssler, Ph.D., COO Europe, Bachem AG, Switzerland
"TIDES is an excellent opportunity to connect with the Oligo Industry, staying abreast of the latest developments while formulating strategies for the future."- Giuseppe Whelan, Project Leader, GlaxoSmithKline
"One of the great things about TIDES, in addition to the excellent program content, is the large exhibit hall which enables me to meet with many of the most relevant suppliers with just one trip."- Christoph Rosenbohm, Ph.D., Senior Director, Research Operations, Santaris Pharma A/S, Denmark
Copyright IBC Life Sciences, a part of Informa Life Sciences Group.Phone: 800.390.4078Email: firstname.lastname@example.org